130 related articles for article (PubMed ID: 9631932)
21. Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples.
Wiegand RF; Klette KL; Stout PR; Gehlhausen JM
J Anal Toxicol; 2002 Oct; 26(7):519-23. PubMed ID: 12423010
[TBL] [Abstract][Full Text] [Related]
22. Urinary excretion profiles of two major triazolam metabolites, alpha-hydroxytriazolam and 4-hydroxytriazolam.
Tsujikawa K; Kuwayama K; Miyaguchi H; Kanamori T; Iwata Y; Inoue H; Kishi T
J Anal Toxicol; 2005; 29(4):240-3. PubMed ID: 15975253
[TBL] [Abstract][Full Text] [Related]
23. Comparison between the CEDIA and EMIT II immunoassays for the determination of benzodiazepines.
Way BA; Walton KG; Koenig JW; Eveland BJ; Scott MG
Clin Chim Acta; 1998 Mar; 271(1):1-9. PubMed ID: 9564553
[TBL] [Abstract][Full Text] [Related]
24. Improved screen and confirmation test of 7-aminoflunitrazepam in urine specimens for monitoring flunitrazepam (Rohypnol) exposure.
Wang PH; Liu C; Tsay WI; Li JH; Liu RH; Wu TG; Cheng WJ; Lin DL; Huang TY; Chen CH
J Anal Toxicol; 2002 Oct; 26(7):411-8. PubMed ID: 12422994
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Two Immunoassay Screening Methods and a LC-MS/MS in Detecting Traditional and Designer Benzodiazepines in Urine.
Rossi B; Freni F; Vignali C; Stramesi C; Collo G; Carelli C; Moretti M; Galatone D; Morini L
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011344
[TBL] [Abstract][Full Text] [Related]
26. Comparison of immunoassay screening tests and LC-MS-MS for urine detection of benzodiazepines and their metabolites: results of a national proficiency test.
Bertol E; Vaiano F; Borsotti M; Quercioli M; Mari F
J Anal Toxicol; 2013; 37(9):659-64. PubMed ID: 23943436
[TBL] [Abstract][Full Text] [Related]
27. Urinary screening for adinazolam and its major metabolites by the Emit d.a.u. and FPIA benzodiazepine assays with confirmation by HPLC.
Fraser AD; Isner AF; Bryan W
J Anal Toxicol; 1993; 17(7):427-31. PubMed ID: 8309217
[TBL] [Abstract][Full Text] [Related]
28. Benzodiazepines identified by capillary gas chromatography-mass spectrometry, with specific ion screening used to detect benzophenone derivatives.
Jones CE; Wians FH; Martinez LA; Merritt GJ
Clin Chem; 1989 Jul; 35(7):1394-8. PubMed ID: 2667799
[TBL] [Abstract][Full Text] [Related]
29. LC-MS/MS analysis of 13 benzodiazepines and metabolites in urine, serum, plasma, and meconium.
Marin SJ; McMillin GA
Methods Mol Biol; 2010; 603():89-105. PubMed ID: 20077062
[TBL] [Abstract][Full Text] [Related]
30. Comparison of LUCIO®-direct ELISA with CEDIA immunoassay for 'zero tolerance' drug screening in urine as required by the German re-licensing guidelines.
Agius R; Nadulski T; Kahl HG; Dufaux B
Drug Test Anal; 2013 Jun; 5(6):390-9. PubMed ID: 23349145
[TBL] [Abstract][Full Text] [Related]
31. Measurement of benzodiazepines in urine by liquid chromatography-tandem mass spectrometry: confirmation of samples screened by immunoassay.
Glover SJ; Allen KR
Ann Clin Biochem; 2010 Mar; 47(Pt 2):111-7. PubMed ID: 19969595
[TBL] [Abstract][Full Text] [Related]
32. Quantitation of benzodiazepines in blood and urine using gas chromatography-mass spectrometry (GC-MS).
Goldberger BA; Chronister CW; Merves ML
Methods Mol Biol; 2010; 603():75-87. PubMed ID: 20077061
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the Microgenics CEDIA heroin metabolite (6-AM) and the Roche Abuscreen ONLINE opiate immunoassays for the detection of heroin use in forensic urine samples.
Holler JM; Bosy TZ; Klette KL; Wiegand R; Jemionek J; Jacobs A
J Anal Toxicol; 2004 Sep; 28(6):489-93. PubMed ID: 15516301
[TBL] [Abstract][Full Text] [Related]
34. Benzodiazepine screening using EMIT II and TDx: urine hydrolysis pretreatment required.
Meatherall R
J Anal Toxicol; 1994; 18(7):385-90. PubMed ID: 7861751
[TBL] [Abstract][Full Text] [Related]
35. Urine levels of drugs for which Triage DOA screening was positive.
Moriya F
Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S434-6. PubMed ID: 19261513
[TBL] [Abstract][Full Text] [Related]
36. Detectability of new psychoactive substances, 'legal highs', in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuse.
Beck O; Rausberg L; Al-Saffar Y; Villen T; Karlsson L; Hansson T; Helander A
Drug Test Anal; 2014 May; 6(5):492-9. PubMed ID: 24665024
[TBL] [Abstract][Full Text] [Related]
37. Urinalysis of alpha-hydroxyalprazolam, alpha-hydroxytriazolam, and other benzodiazepine compounds by GC/EIMS.
Dickson PH; Markus W; McKernan J; Nipper HC
J Anal Toxicol; 1992; 16(2):67-71. PubMed ID: 1501466
[TBL] [Abstract][Full Text] [Related]
38. Detection of benzodiazepines and tribenzazolams by TRIAGE: confirmation by solid-phase extraction utilizing SPEC.3ML.MP3 microcolumns and GC-MS.
Edinboro LE; Poklis A
J Anal Toxicol; 1994 Oct; 18(6):312-6. PubMed ID: 7823538
[TBL] [Abstract][Full Text] [Related]
39. Improved buprenorphine immunoassay performance after urine treatment with β-glucuronidase.
Snyder ML; Darragh A; Flood JG; Jones J; Ropar K; Jarolim P; Melanson SE
J Anal Toxicol; 2014; 38(6):375-9. PubMed ID: 24802159
[TBL] [Abstract][Full Text] [Related]
40. Urinary screening for alprazolam and its major metabolites by the Abbott ADx and TDx analyzers with confirmation by GC/MS.
Fraser AD; Bryan W; Isner AF
J Anal Toxicol; 1991; 15(1):25-9. PubMed ID: 2046338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
